Jasper Therapeutics (JSPR) Insider Trading & Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free JSPR Stock Alerts $21.33 -0.09 (-0.42%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Jasper Therapeutics (NASDAQ:JSPR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.90%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$4.54 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$45,502.00 Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address JSPR Insider Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Jasper Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/12/2024Jeetinder Singh MahalCOOSell900$26.44$23,796.00 2/8/2024Velan Capital Investment ManagMajor ShareholderBuy350,000$12.95$4,532,500.00 11/20/2023Thomas G WiggansDirectorBuy1,000$6.30$6,300.00 11/16/2023Thomas G WiggansDirectorBuy1,000$6.00$6,000.00 10/13/2023William LisDirectorSell796$8.50$6,766.00 6/13/2023Jeetinder Singh MahalInsiderSell900$16.60$14,940.00 (Data available from 1/1/2013 forward) JSPR Insider Trading Activity - Frequently Asked Questions Who is on Jasper Therapeutics's Insider Roster? The list of insiders at Jasper Therapeutics includes Anna Louise French, Carlyle Group Inc., Holding Ltd Roche, Jeetinder Singh Mahal, Thomas G Wiggans, Velan Capital Investment Manag, and William Lis. Learn more on insiders at JSPR. What percentage of Jasper Therapeutics stock is owned by insiders? 3.90% of Jasper Therapeutics stock is owned by insiders. Learn more on JSPR's insider holdings. Which Jasper Therapeutics insiders have been buying company stock? The following insiders have purchased JSPR shares in the last 24 months: Carlyle Group Inc. ($4,699,995.00), Thomas G Wiggans ($12,300.00), and Velan Capital Investment Manag ($4,532,500.00). How much insider buying is happening at Jasper Therapeutics? Insiders have purchased a total of 665,333 JSPR shares in the last 24 months for a total of $9,244,795.00 bought. Which Jasper Therapeutics insiders have been selling company stock? The following insiders have sold JSPR shares in the last 24 months: Anna Louise French ($10,360.00), Holding Ltd Roche ($141,750.00), Jeetinder Singh Mahal ($38,736.00), and William Lis ($108,200.00). How much insider selling is happening at Jasper Therapeutics? Insiders have sold a total of 15,744 Jasper Therapeutics shares in the last 24 months for a total of $299,046.00 sold. More Insider Trading Tools from MarketBeat Related Companies: TNYA Insider Transactions DCGO Insider Transactions BDTX Insider Transactions OCGN Insider Transactions AURA Insider Transactions SLDB Insider Transactions CRBU Insider Transactions MGTX Insider Transactions REPL Insider Transactions TRML Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:JSPR) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.